Fast Forwarding Drug Discovery

Home Testimonials

Testimonials

"We have been using the services offered by Pharmidex for more than 5 years now, and the extent to which we have relied upon your support has increased year on year since 2003. We have been consistently impressed by the level of service that we have received. In all aspects of your work you have demonstrated the highest standards of professionalism and have provided exemplary levels of commitment, flexibility, confidentiality and value for money. In several instances this has enabled us to accelerate discovery programmes and make key decisions earlier than we would otherwise have been able to using internal capacity."
CEO, major UK biotechnology company now part of Astrazenca
"The expertise that Pharmidex has to offer in tackling problems will prove very valuable to clients, enabling them to avoid blind alleys and to accelerate their drug development projects."
Vice President, Neuroscience Research, top 10 global major pharmaceuticals based in UK.
Pharmidex is tackling one of the major issues which faces all neuroscience drug discovery organizations“ good and timely DMPK, and generation of blood brain barrier penetration data.
Vice president, Neuroscience research, top three global Pharma, New jersey, USA
A particular problem which drug discovery companies encounter is the relationship between blood and brain levels and the actual pharmacodynamic response in the brain. I therefore welcome the Pharmidex initiative in the area of NeuroPK which is designed to address these issues and I confirm that your technology is novel.
Director of depression and anxiety research for one of the top three global major pharmaceuticals based in Europe.
 

Contact us

Your email address:
Subject:
Message: